ποΈ Episode 34: MS Meds After 55? Time for a Pause ?
Manage episode 478124857 series 3659512
π§ͺ Study:
Patients β₯55 with no relapses in 5 yrs and no new lesions in 3 yrs may stop disease-modifying therapy (DMT).
No significant difference in disability progression.
π§© Clinical Takeaway:
De-escalation strategy in stable MS may reduce cost and side effects.
Still requires close neurology follow-up.
Please visit www.Brilliantcourses.com to reflect on this activity with Learner+ platform to earn CME/CE.
45 episodes